Irene J. Virgolini

Irene Johanna Virgolini (born December 29, 1962) is an Austrian nuclear medicine physician, professor, and director of the University Clinic for Nuclear Medicine at the Medical University of Innsbruck.

Life Virgolini studied medicine at the University of Vienna from 1981 to 1987. She first gained interest in medical research at the Institute of Human Genetics at the University of Vienna. This was further deepend during a study visit to the Sackler Medical School at Hasharon Hospital, Tel Aviv University in Israel. She subsequently began her research career in 1985, focusing on atherosclerosis research at the Institute of Physiology at the University of Vienna. Parallel to her research activities, she began training in internal medicine with a specialization in nuclear medicine at the University Hospital Vienna in 1987, where she initially served as an assistant physician and later, until 2000, as a senior physician.

Research

Scientific focus Virgolini's clinical research focuses on the development and preclinical validation of new radiopharmaceuticals for nuclear medicine diagnostics and therapy. Under Virgolini's leadership, several new nuclear medicine Tracer-Procedures (Positron-Emissions-Tomography - PET and SPECT) have been clinically established. Her clinical research focuses on the field of neuroendocrine tumor diseases and the nuclear medicine treatment of prostate cancer. Moreover, her research also focuses on patient-related quality of life in the context of individualized high-dose therapy.

Publications and lectures Virgolini's scientific work has appeared in over 500 publications in medical journals (1990–2024: total impact factor 1000, citation index 10000, Hirsch-Index 50, based on "Web of Science"). Since 1988, Virgolini has been invited to international conferences and universities and faculties in Austria and abroad to give lectures on the subject of "Molecular Imaging and Therapy".

Selected publications

In 1997, Virgolini was granted a patent for a carrier substance for radionuclides for the diagnosis and destruction of tumor tissue (Vienna Patent Office), and in 1998 an EU patent for radiolabeled somatostatin receptor ligands for diagnosis and therapy.

Awards Some of the approximately 30 national and international prizes and awards that Virgolini has received for her scientific work:

1992: Award of the International Union of Angiology, Paris 1992 und 1994: Jean Debiesse Award der European Association of Nuclear Medicine (EANM), Lissabon/Düsseldorf 1996: Martin-Gülzow Award der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten, Aachen 1996 und 2008: Editorial Board Award of the Journal of Nuclear Medicine, Denver/New Orleans 1997: Mac Foster Award der European Society of Clinical Investigation 2008 und 2010: Alavi-Mandell Award der Society of Nuclear Medicine (SNM), New Orleans/Salt Lake City 2012: EANM-Springer-Preis Best Basic Science Paper 2011, Mailand. 2018: Unter Federführung von Christian Uprimny: 1. Rudolf-Höfer-Preis, Innsbruck 2018: EANM-Springer-Preis Best Paper 2018, Düsseldorf. 2019: Preis der Ärztekammer für Tirol 2018, Innsbruck. 2020: Ilse-Zoller-Förderungspreis für Naturwissenschaften, Zell am See. 2024: Österreichischer Schilddrüsenpreis 2024, Innsbruck.

Literature

Nuclear Medicine Innsbruck celebrates its 50th anniversary. In: Glandula. Journal of the Neuroendocrine Tumors Network (NeT). 16, 2011, p. 20.